StockNews.com began coverage on shares of Mesoblast (NASDAQ:MESO – Free Report) in a report released on Thursday morning. The brokerage issued a sell rating on the stock. A number of other research analysts have also recently weighed in on the stock. Piper Sandler cut shares of Mesoblast from an overweight rating to a neutral rating […]
Lazari Capital Management Inc. purchased a new position in shares of Mesoblast Limited (NASDAQ:MESO – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 86,034 shares of the company’s stock, valued at approximately $336,000. Lazari Capital Management Inc. owned approximately 0.05% of Mesoblast at […]
Mesoblast Limited (NASDAQ:MESO – Get Free Report) saw a large drop in short interest during the month of September. As of September 15th, there was short interest totalling 941,200 shares, a drop of 15.2% from the August 31st total of 1,110,000 shares. Based on an average daily volume of 522,000 shares, the short-interest ratio is […]